ReNeuron Banner Image


  • Ticker RENE
    Exchange LSE More
  • Industry Biotechnology More
  • Sector Healthcare More
ReNeuron Logo Image
  • 11-50 Employees
  • Based in Bridgend, Wales
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate that is in partnering stage in china and outside china for treating stroke disability; and human retinal progenitor cell therapy that is in Phase I/IIa clinical trial for treating retinitis pigmentosa, a blindness-causingMore disease.
4.8 / 5.0 (155)

ReNeuron reports have an aggregate usefulness score of 4.8 based on 155 reviews.


Most Recent Annual Report

MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

ReNeuron Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!